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Summary Although patients with atrial ﬁbrillation (AF) have an increased risk of embolic
stroke, some clinicians hesitate to provide anticoagulation therapy for these patients dur-
ing electroconvulsive therapy (ECT), which is widely applied for the treatment of intractable
depression, bipolar disorder, and catatonic schizophrenia, because of potential intracerebraltherapy;
Anticoagulation
hemorrhage. We report on a 77-year-old female depressive patient with AF treated with aspirin
but not on anticoagulation therapy because of poor compliance who developed embolic stroke
1 day after the last ECT. The CHADS2 score of this patient was 2 and included the age and
hypertension. The present case suggests that anticoagulation therapy should be considered for
patients with obvious risks of embolic stroke when they are subjected to ECT.
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lectroconvulsive therapy (ECT) is widely performed against
ntractable depression, bipolar disorder, and catatonic
chizophrenia. Although anticoagulation therapy is recom-
ended for patients with atrial ﬁbrillation (AF) to prevent
mbolic stroke before having ECT [1—3], some investigators
onsider anticoagulation as a factor increasing the risk of
ntracerebral hemorrhage during ECT [4] probably because
CT elicits a transient increase in blood pressure. As far
s we know, there is no report demonstrating that embolic
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troke developed after ECT in patients with AF. We report
ere a case with depression and AF with obvious risk factors
f stroke but not on anticoagulation therapy with warfarin
ho developed embolic stroke after ECT.
ase report
77-year-old woman with chronic AF developed acute cere-
ral stroke 1 day after her 43rd ECT. The ﬁrst ECT for this
atient was operated 2 years before the onset of stroke
ecause of severe depression refractory to medication ther-
py. She was admitted the Department of Psychiatry for
radual exacerbation of depressive symptoms 21 days before
he stroke event. Her medications were aspirin, enalapril,
nd ﬂunitrazepam. She had hypertension as a major risk
Published by Elsevier Ireland Ltd. All rights reserved.
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EFigure 1 Magnetic resonance imaging at the onset of cerebr
diffusion-weighted magnetic resonance image (A). The upper t
resonance angiography (B). Arrowheads indicate regions of inte
factor of cerebral stroke, but had no history of cerebral
ischemic events, diabetes, or heart failure. Although her
CHADS2 score [5] was 2, she had not had anticoagula-
tion therapy with warfarin because of poor compliance.
Transthoracic echocardiography performed 19 days before
the onset of stroke revealed that left ventricular ejec-
tion fraction was 71% and there was no obvious thrombus
although the left atrium was enlarged with a diameter of
5.3 cm and moderate aortic and mitral regurgitations were
found. Her previous 42 ECTs had been all operated without
any remarkable complications.
The 43rd ECT was safely operated at 14.00 h using the
Thymatron System IV (Somatics, LLC, Lake Bluff, IL, USA)
with brief-pulse square-wave currents. Before ECT was
initiated, electrodes were placed in the traditional bilat-
eral front-temporal manner, and atropin sulfate (0.25mg)
[6], landiolol (5mg) [7], midazolam (10mg), and succinyl-
choline (60mg) were administered intravenously. Motor
and electroencephalogram seizures lasting for 42 s and 56 s
respectively were produced by the electrical stimulation.
The parameters of ECT were as follows: electrical charge
of 60% (297.2 millicoulombs [mC]), current of 0.88 A, stimu-
lus duration of 6.7 s, frequency of 50Hz, and pulse width
of 0.50ms. Flumazenil (0.3mg) and nicardipine (0.5mg)
[8] were injected intravenously after the termination of
seizure. Blood pressure and heart rate before ECT were
119/59mmHg and 65 bpm respectively. The maximal blood
pressure and heart rate during ECT were 145/83mmHg and
83 bpm respectively. The heart rhythm was not converted to
sinus rhythm during ECT. She was neurologically normal 1 h
after the ECT.
At 13.00 h the next day, she suddenly fell down while
she was walking in her room with right conjugate devia-
tion of the eyes and left hemiplegia. Diffusion-weighted
magnetic resonance imaging demonstrated diffusion in the
right temporo-parietal region (Fig. 1A). Magnetic resonance
angiography revealed occlusion of the upper trunk of the
middle cerebral artery (Fig. 1B). She was diagnosed as having
embolic stroke because of sudden onset of the symptoms and
the existence of AF without anticoagulation therapy. After
treatment with heparin, edarabone, glycerol, and mannitol
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sroke. The right temporo-occipital lobe was highly diffused on
of the right middle cerebral artery was occluded on magnetic
er symptoms were rapidly relieved, and only slight muscle
eakness remained in her left arm and leg 7 days after the
nset of stroke.
iscussion
he patient with chronic AF developed acute cerebral stroke
day after ECT. To the best of our knowledge, there is only
ne report of thromboembolic stroke that was associated
ith ECT in a patient without AF [9]. Direct electrical inﬂu-
nce of ECT on the heart has been reported to be negligible.
iltay et al. reported that intracardiac electrogram of a
ual-chamber sensing VDDR pacemaker showed low noise
ignals of around 2mV, which elicited oversensing in the
trium only during ECT [10]. Although arrhythmias such as
trial ﬂutter and AF have been reported to develop after ECT
robably due to the activation of parasympathetic tones in
he early stage or that of sympathetic ones in the later stage
6,11,12], AF persisted during and after ECT in the present
atient. Therefore, it is unlikely that the effect of ECT itself
n electrical activity of the heart was responsible for the
mbolic stroke in the present case.
Embolic stroke is a well-known hazardous complication
f AF. Therefore, anticoagulation therapy with warfarin is
ecommended for patients with a CHADS2 index of 2 or more
13]. The index of the present patient was 2 because her
ondition satisﬁed age over 75 years and hypertension, both
f which are deﬁnite risk factors of cerebral stroke.
Patients with depression have enhanced platelet reac-
ivity and aggregation [14—17]. Some reports support the
otion that depression itself is an independent risk fac-
or of cerebral stroke [18]. Moreover, Stain-Malmgren et
l. demonstrated that 5-H2-receptor densities of platelets
n patients with depression were increased after repeated
CT [19], which might enhance platelet reactivity and might
ncrease the risk of embolic stroke. Therefore, the pos-
ibility of thrombotic events like cerebral stroke may be
ubstantially higher in depressive patients subjected to ECT
ncluding the present patient than in ordinary AF patients. In
ummary, multi-factorial mechanisms, that is, no warfarin
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se and enhanced reactivity and aggregation of platelets
ue to the existence of depression and repeated ECT may
e responsible for the embolic stroke developed 1 day after
he 43rd ECT in the present patient.
Anticoagulation therapy may increase the risk of intrac-
rebral hemorrhage during ECT. As far as we know, however,
nly two cases with intracerebral bleeding were actually
eported after ECT [20,21]. Furthermore, there is a report
emonstrating that ECT in patients on anticoagulation ther-
py appears to be safe [22]. Considering the high annual
troke-event rate in patients with AF and obvious risk fac-
ors of cerebral stroke [13], it should be reasonable for these
atients to have anticoagulation therapy especially when
hey undergo ECT for the management of depression.
Anticoagulation therapy with warfarin is recommended in
dose adjusted to achieve the target intensity international
ormal ratio (INR) of 2.0—3.0 for patients with AF at high
isk of cerebral infarction [13]. However, the patient age and
ntensity of anticoagulation are powerful predictors of major
leeding. A lower target INR of 1.6—2.5 may be considered
or primary prevention of cerebral stroke in patients with AF
5 years and older with increased risk of bleeding [13]. As
e could not exclude the possibility that ECT is one of the
isks of cerebral bleeding [20,21], the lower target intensity
NR would be preferable especially in patients aged 75 years
nd older as in the case of the present patient.
When surgical procedures require interruption of oral
nticoagulation therapy in patients with AF at high risk
f cerebral infarction, unfractionated heparin or low-
olecular-weight heparin may be given intravenously or
ubcutaneously, although the efﬁcacy has not been estab-
ished fully [13]. Whether the temporary discontinuation of
arfarin and use of heparin should be considered in patients
n anticoagulation therapy and requiring ECT remains to be
lucidated [4].
Finally, transesophageal echocardiography is recom-
ended for patients undergoing cardioversion who have
ot been on anticoagulation therapy [13]. It should also
e clariﬁed in future studies whether patients subjected to
CT without anticoagulation therapy should be screened for
hrombus in the left atrium using transesophageal echocar-
iography.
onclusion
lthough there is a potential risk of intracerebral hem-
rrhage, anticoagulation therapy should be considered for
atients with AF and obvious risks of cerebral stroke when
hey are subjected to ECT.
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